Follistatin Gene Therapy Builds Muscle, Reduces Inflammation

D

Dr. Adeel Khan on Mark Hyman's podcast

Quotes From Source

“Follistatin helps put on more muscle by reducing myostatin.”

Story of claim

Follistatin gene therapy reduces myostatin, enhancing muscle mass and lowering inflammation, especially beneficial for adults over 60 experiencing muscle loss.

  • Goal: To increase muscle mass and reduce systemic inflammation in older adults.
  • Proof: Follistatin decreases myostatin, an inhibitor of muscle growth, thereby preserving muscle and reducing inflammation.
  • Nuances:
    • Follistatin is anticatabolic, preventing tissue loss with age.
    • Follistatin benefits outweigh theoretical long-term risks.
  • Impact on Life: Potential for improved strength and reduced inflammation, enhancing mobility and quality of life in elderly.

Investments

  • Price: High initial cost for gene therapy sessions
  • Time: Requires ongoing medical supervision
  • Effort: Regular monitoring and medical consultations needed

Risks

Theoretical long-term risks due to gene therapy.

Get Started 🚀

  • Consult with a regenerative medicine specialist.
  • Assess eligibility for Follistatin gene therapy.
  • Plan for regular follow-up and monitoring.

Brogevity AI can make mistakes. Check important info.

Reference Video